Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Trials, Studies and Programs: Diverse Operational Approaches to Generating Evidence in the Late-phase Environment

Session Chair(s)

Gary  Coward

Gary Coward

PAREXEL International, United Kingdom

Generating Momentum in Post-authorization Studies

Learning Objective : Identify three different operational approaches to generating real-world evidence on the usage, effectiveness, and safety of a pharmacological intervention in a late-phase environment; Discuss advantages of adopting a considered risk-based approach to site monitoring; Describe the benefits of using a managed access program; Discuss how to ensure a successful observational study outcome.

Speaker(s)

Gary  Coward

Generating Momentum in Post-authorization Studies

Gary Coward

PAREXEL International, United Kingdom

Heather L Manna

Use of Expanded Access Program (EAP) Data to Gain New Insights into Drug Efficacy and Safety

Heather L Manna

Idis Pharma, United States

Senior Manager, Regulatory Affairs

Bill  Row, MBA, MS

Risk-based Approach to Monitoring in Late-phase Clinical Trials

Bill Row, MBA, MS

Mapi, United States

Senior Director, Clinical Operations Americas

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.